Credit Suisse on Prometheus (RXDX): 'Roivant’s Ph2b UC Results Support Anti-TL1A Approach; Prometheus’ PRA023 Maintains Best-in-Class Profile'

Go back to Credit Suisse on Prometheus (RXDX): 'Roivant’s Ph2b UC Results Support Anti-TL1A Approach; Prometheus’ PRA023 Maintains Best-in-Class Profile'
(NASDAQ: ROIV) Delayed: 36.30 -0.54 (1.47%)
Previous Close $36.84    52 Week High
Open $37.03    52 Week Low
Day High $37.18    P/E N/A 
Day Low $36.23    EPS
Volume 6,185,594       

IGNYTA (NASDAQ: RXDX) Delayed: 199.92 --0 (-0%)
Previous Close $199.92    52 Week High $15.20 
Open $10.02    52 Week Low $4.15 
Day High $199.92    P/E N/A 
Day Low $199.92    EPS $-0.44 
Volume 417,305